Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-1130.93%EBITDA Margin
VS
Market
Sector
Industry
History
$ 5.8Close
$ 4.78 - $ 13.59 52-Week Range
Ticker Information
Ticker
BOLTCompany Name
BOLT BIOTHERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQBOLT BIOTHERAPEUTICS INC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
BOLT - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -47.13M | -1130.93% | $ 4.17M |
| 3/31/2025 | $ -59.49M | -1635.13% | $ 3.64M |
| 12/31/2024 | $ -59.04M | -767.75% | $ 7.69M |
| 9/30/2024 | $ -60.14M | -615% | $ 9.78M |
| 6/30/2024 | $ -61.26M | -548.62% | $ 11.17M |
| 3/31/2024 | $ -58.18M | -513.75% | $ 11.32M |
| 12/31/2023 | $ -64.39M | -817.56% | $ 7.88M |
| 9/30/2023 | $ -66.54M | -924.47% | $ 7.2M |
| 6/30/2023 | $ -72.13M | -1063.55% | $ 6.78M |
| 3/31/2023 | $ -76.85M | -1139.88% | $ 6.74M |
Key Performance Insights, Last 5 Years
- BOLT BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) EBITDA % stands at -25205.19%.
- Over the past 5 years, BOLT BIOTHERAPEUTICS INC's average EBITDA % has been -3856.02%.
- The median EBITDA % for BOLT BIOTHERAPEUTICS INC during this period was -1139.88%
- BOLT BIOTHERAPEUTICS INC reached its highest EBITDA % over the past 5 years at -513.75%.
- The lowest EBITDA % recorded by BOLT BIOTHERAPEUTICS INC in the same timeframe -25205.19%
BOLT BIOTHERAPEUTICS INC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for BOLT BIOTHERAPEUTICS INC is calculated as follows: EBITDA [ $ -58.22M ] / Revenues [ $ 231K ]
(=) EBITDA % [ -25205.19% ] BOLT - EBITDA Margin, Last 5 years
-25205.19%
Minimum
Dec 31, 2020
-513.75%
Maximum
Mar 31, 2024
-3856.02%
Average
-1139.88%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.2% with a standard deviation of 26.73%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -74.33% |
| max | 97.24% |
| average | 16.2% |
| median | 14.74% |
| std | 26.73% |